Equity
-€230,528
Debts exceed assets in financial year 2025.
PLANIMED
Lifetime
10 annual accounts with figures on one time axispeak €1.2m (2019)
€85,948▲ €448,425
lowest -€419,359 (2024)
€31,168▲ €450,527
peak €688,137 (2018)
-€230,528▲ €31,168
€410,567▼ 18.9%
peak 11.9 FTE (2018)
0.8 FTEunchanged
Board2 names since 2023
2 directorsHenri MAZY and 1 other
Owners
100%PLANI INVEST
Documentsfilings and deeds
31-03-2026122 days before the deadline
2025financial year
Gross margin from -€362,477 to €85,948Back to profit: €31,168Debts from €506,066 to €410,567Cash from €39,463 to €14,047
Key points
from the 2025 annual accountsResult
€31,168 €31,168
Back in profit in 2025, after a loss of €419,359 in 2024.
Debts
€410,567 228% of the balance sheet
Suppliers 5%Taxes and wages 2%Other 93%
Of this, €126,803 falls due within a year.
Staff
0.8 FTE from 11.9 in 2018
Between 2018 and 2025, 93% of the full-time equivalents disappeared.
Filings
10 annual accounts 4 late
The 2016 accounts came latest: 29 days after the end of the period.
Position in the sector
-128.0%
Lower solvency than 95% of companies in human health. Sector median 57.8% · 784 companies.
Checked score
54
Fair
Financially stronger than 22% of micro companies in human health (NACE 86)
Probability in this band: 1.5% to 4.2%
Negative equity caps the score at 59.
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%lowest value
01-2025: 0.1%● unchanged vs 12-2024lowest value
02-2025: 0.1%● unchanged vs 01-2025lowest value
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.9%▲ +0.8 percentage points vs 03-2025
05-2025: 0.9%● unchanged vs 04-2025
06-2025: 0.9%● unchanged vs 05-2025
07-2025: 0.9%● unchanged vs 06-2025
08-2025: 0.9%● unchanged vs 07-2025
09-2025: 0.9%● unchanged vs 08-2025
10-2025: 0.9%● unchanged vs 09-2025
11-2025: 0.9%● unchanged vs 10-2025
12-2025: 0.9%● unchanged vs 11-2025
01-2026: 0.9%● unchanged vs 12-2025
02-2026: 0.9%● unchanged vs 01-2026
03-2026: 1.0%▲ +0.1 percentage points vs 02-2026highest value
04-2026: 0.3%▼ -0.7 percentage points vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: 0.3%● unchanged vs 07-2026
09-2026: 0.3%● unchanged vs 08-2026
10-2026: 0.3%● unchanged vs 09-2026
11-2026: 0.3%● unchanged vs 10-2026
Financial strengthWeak
Score breakdown
raises risk
Capped at 59: negative equity
Negative equity -€230,528
lowers risk
Sector: Human health activities (NACE 86)
Size: 0.8 FTE, total assets €180,039
Figures for financial year 2025 (filed on 31-03-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 1% of them on solvency, 3% on liquidity, 27% on profitability and 55% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 3,632 companies had the same profile as PLANIMED has now. Each dot stands for 10 companies, two years later.
91.8%
were still trading
4.8%
stopped another way
2.9%
went bankrupt
Another 0.4% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of PLANIMED itself is lower: 0.3% within 12 months. It rests on far more data about PLANIMED than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,632 companies, not a prediction for PLANIMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
No credit on open account
Liquidity is tight, with a current ratio of 1.42 (2.03 in 2024), below the usual 1.5. Short-term debt is 70.4% and cash 7.8% of total assets. Equity is negative.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 784 sector peers (2025).
NBB · sector comparisonPosition among 784 sector peers
Solvency
better than 5%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-03-2026, 122 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
122 days early
2024
126 days early
2023
34 days early
2022
124 days early
2021
143 days early
2020
32 days early
2019
27 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 79 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 March (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- PLANI INVEST 100%score 89equity €1.7m (2025) · annual accounts 2025
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0846356474
Appointments: Henri MAZY (director) and RIZZO Giuseppa (director)
Legal-form conversion: from private limited company (pre-2019) to private limited company · Director discharge: Henri MAZY · Director discharge: RIZZO Giuseppa · General meeting of 29-12-2023 · Gazette deed
Incorporation
published on 14-06-2012 · Gazette deed
First establishment
Rue Patenier 43, Seraing
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PLANIMED Seraing | €180,039 | €85,948 | -128.0% | 0.8 |
| anne-soins Binche | €135,368 | €55,884 | 30.6% | 0.3 |
| VERCOUTER BRIGITTE Mons | €231,847 | €125,561 | 83.8% | 1 |
| AT HOME NURSING Andenne | €115,678 | €176,717 | 74.7% | 1 |
| CJ Soins Grâce-Hollogne | €176,291 | €90,812 | 81.7% | - |
| YVES-LAURENT DEHAN Héron | €151,071 | €101,578 | 84.2% | - |
| Ravan Belgique Saint-Nicolas | €150,284 | €89,693 | 17.4% | - |
These companies have the same main activity as PLANIMED: nursing and midwifery (NACE 86940). They are comparable in size and age: total assets between €116,000 and €232,000, founded between 2000 and 2017.
Official details
Source: KBO- Status
- Active since 05-06-2012Normal situation
- Registered office
- 13 active companies are registered at this addressSource: KBO register, as of 10 November 2026.
- Activity
- Nursing and midwiferyNACE 86940
- Establishment unit
- 2.209.873.8934100 Seraing, since 01-06-2012
- Financial year end
- 31 December
- Peppol
- Reachable since 09-12-2025
Annual accounts 2025
- ≈ €240,000estimated
- €180,039▼ 26.3%
- Employeeson 31-12-2025
- 3=
- Filing
- Filed on 31-03-2026, 122 days before the end of the filing period
Insights on PLANIMED
PLANIMED has existed since 2012. The gross margin fell from €1.2m in 2019 to €52,470 in 2022 and staff from 11.8 to 0.5 full-time equivalents.
Solvency fell in 2025 from -107.1% to -128.0%.
PLANI INVEST holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PLANIMED
- What is the company number of PLANIMED?
- The company number of PLANIMED is 0846.356.474. The VAT number is the same number with BE in front: BE 0846.356.474.
- Where is PLANIMED based?
- The registered office is at Rue Patenier 43, 4100 Seraing.Company details
- What does PLANIMED do?
- According to the KBO register, the main activity is nursing and midwifery (NACE 86940).
- What is the legal form of PLANIMED?
- PLANIMED is a private limited company (BV).
- When was PLANIMED founded?
- PLANIMED was founded on 05-06-2012.
- Is PLANIMED still active?
- Yes, PLANIMED is an active enterprise in the KBO register.
- How many employees does PLANIMED have?
- PLANIMED had an average of 0.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of PLANIMED?
- The turnover in financial year 2025 is ≈ €240,000. This figure is estimated from the gross margin of €85,948 and 33 comparable companies (NACE 869). It probably lies between €150,000 and €350,000.
- Is PLANIMED profitable?
- In financial year 2025, PLANIMED made a profit of €31,168.
- Where can I find the annual accounts of PLANIMED?
- PLANIMED filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PLANIMED due?
- PLANIMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.